✦ LIBER ✦

PAO6: COST-EFFECTIVENESS ANALYSIS OF USING CELECOXIB IN THE TREATMENT OF OSTEOARTHRITIS

✍ Scribed by J Soto; J Rejas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB C

✍ JC Sambrook; AR Levy; K Osenenko; C Kindundu; M Barbeau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PAO5: COST ANALYSIS OF CELECOXIB AND CON

✍ JH You; KK Lee; FK Chan; SS Ho; TY Chan; PS Au; WH Lau 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PAO6 COST-EFFECTIVENESS OF BISPHOSPHONAT

✍ RT Burge; D Grima; D Becker; AN Tosteson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PAO4 COST ANALYSIS OF A 12-WEEK CYCLE OF

✍ S Chiroli; DP Roggeri 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PAO4: THE COST-EFFECTIVENESS OF CELECOXI

✍ E Orlewska 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

The cost effectiveness of rofecoxib and

✍ Maetzel, Andreas ;Krahn, Murray ;Naglie, Gary 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views